Endometriosis is a condition characterized by the presence of tissue similar to the uterine lining outside the uterine cavity. Symptoms include severe pain during menstruation and difficulties in conceiving. In Poland, according to the Central Statistical Office data, approximately 400,000 women suffer from endometriosis. In Europe, it is estimated to affect from 2% to 10% of women of reproductive age.
Uterine fibroids, also known as uterine leiomyomas, are benign tumors that develop in the uterine muscle tissue. They are prevalent among many women, particularly during their reproductive years. In Europe, approximately 20-40% of women of reproductive age have uterine fibroids. In Poland, specific statistics regarding the number of cases are lacking, but they represent a significant health issue that necessitates effective therapeutic approaches.
Malignant tumors pose a significant challenge for patients and the healthcare system. The uncontrolled growth of cells leads to the formation of tumors that can spread to other parts of the body. In Poland, malignant tumors are the second leading cause of death and account for about 25% of all deaths. In Europe and globally, the number of malignant tumors continues to rise, underscoring the need for effective methods of prevention and treatment.
Hormone replacement therapy
Hormone replacement therapy (HRT) is a method of treating menopausal symptoms by administering hormones that the body stops producing. While effective in alleviating bothersome issues like hot flashes and sleep disturbances, it also carries certain risks and limitations. In Europe and the United States, the number of women using hormone replacement therapy is approximately 15-20%.